TITLE

Review: Evidence for major benefits and harms of antidiabetic agents for diabetes with heart failure is limited

PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a clinical study that evaluates the relation between antidiabetic therapy, morbidity and mortality in patients with heart failure and diabetes. A randomized controlled trials showed that the metformin was associated with lower risk for mortality compared to other antidiabetic drugs. The study concludes that the metformin and thiazolidinediones are linked with reduced risk, but insulin is linked with increased risk for mortality in patients with heart failure and diabetes.
ACCESSION #
28694422

 

Related Articles

  • Does metformin prevent diabetes in at-risk adults? Mangahas, Theresa; Huang, Grace; Neher, Jon; Safranek, Sarah; Kelsberg, Gary // Journal of Family Practice;Aug2013, Vol. 62 Issue 8, p436 

    The article presents an answer to a question of whether metformin helps in reducing the risks of diabetes in adults.

  • Modernes Therapieschema zur Behandlung von Patienten mit Diabetes mellitus Typ 2.  // Praxis (16618157);9/4/2013, Vol. 102 Issue 18, p1083 

    No abstract available.

  • COMMENTARY: Review: Evidence for major benefits and harms of antidiabetic agents for diabetes with heart failure is limited. Lingegowda, Vijaykumar // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p4 

    The author comments on the study concerning the relationship of antidiabetic drugs with heart diseases. He asserts that the randomized controlled trial presents a potential selection bias in different treatment groups such as the insulin therapy. He suggests that the study should take a...

  • metformin.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1456 

    A definition of the term "metformin" is presented.

  • Generic metformin smells fishy? Elliott, William T. // Neurology Alert;Apr2010 Primary Care, p2 

    The article discusses the reason behind the fishy odor and taste of antidiabetic drug metformin and suggests an alternative in order to tolerate the smell.

  • Metformin may increase risk of thyroid problems.  // GP: General Practitioner;9/29/2014, p19 

    The article reports on a study that claims that oral antidiabetic drug metformin has been associated with a high risk of low thyroid stimulating hormone levels in patients with hypothyroidism, which potentially exposing them to cardiovascular disease.

  • ANTIDIABETIC AGENTS.  // Monthly Prescribing Reference;Aug2012, Vol. 28 Issue 8, p108 

    A chart is presented which shows the drug information of several antidiabetic agents such as acarbose, metformin, and sitagliptin.

  • Metformin overdose.  // Reactions Weekly;Sep2015, Vol. 1568 Issue 1, p190 

    The article presents a case study of a 17-year-old female patient who developed lacticaemia and diarrhoea after taking metformin in a suicidal attempt.

  • Metformin.  // Reactions Weekly;Oct2015, Vol. 1574 Issue 1, p179 

    The article presents a case study of a 78-years-old woman who developed periaortitis after being treated with metformin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics